As COVID-19 cases and hospitalizations surge to new highs, states, health systems, and the public continue to need clarity on health care resource allocation policy. A RAND checklist provides clear and consistent criteria for structuring such difficult decisions.
This paper focuses on research stakeholders' views of a model of consent appropriate to biobanking and research infrastructure initiatives like the AoURP and Project Baseline that entail long-term storage and undetermined future research use of multiple types of health data.
The Core Guidance Checklist can help health systems and policymakers make choices about how to allocate scarce but lifesaving resources—for patients and for health care workers—during the COVID-19 crisis.
This report details the results of a survey of institutional research boards (IRBs) to obtain baseline information on their demographics and their attitudes about their IRBs and the likely effects of proposed changes to the Revised Common Rule.
As technology and the ability to gather ever-growing amounts of data move further into the realms of biology and human performance, communication and transparency become increasingly important. Experts should consider whether they are using the words, examples, and models that connect with a broad audience most effectively.
Mainstream interest in genome editing is now surging. If this research is to go forward, the science should be well understood by those conducting the research. Best practices and the highest scientific standards should be employed to limit risks and prevent unintended consequences.
This paper reflects on the variety and evolution of population-scale genome-sequencing initiatives, examining their diverse aims, activities, management and governance approaches, impacts, and policy and research implications.
An overview of ethics and ethical reviews in biomedical research that briefs non-specialists on aspects of the evolution and current debate of biomedical research ethics and assessment of proposed research by ethics committees or review boards.
In its June 1997 report, NBAC agreed that creation of a human child by somatic cell nuclear transfer is scientifically and ethically objectionable at this time. This document provides an update of developments since that time.
Policy Researcher; Professor of Policy Analysis, Pardee RAND Graduate School
Education Ph.D. in philosophy, University of California at Berkeley; M.S. in foreign service, Georgetown University; B.A. in economics and philosophy, New York University
Assistant Policy Researcher, RAND; Ph.D. Student, Pardee RAND Graduate School
Education M.P.H. in health policy and management, Florida A&M University; B.A. in Hispanic studies, University of Tennessee, Knoxville